Medicine and Dentistry
Squamous Cell Carcinoma
100%
Precursor
100%
Adenocarcinoma
100%
Lung Adenocarcinoma
100%
Biological Marker
40%
Dysplasia
20%
Atypical Adenomatous Hyperplasia
20%
Squamous Cell Lung Carcinoma
20%
Urokinase Receptor
20%
Invasive Carcinoma
20%
Bronchial Epithelium
20%
Alveolar Epithelium
20%
Diseases
20%
Non Small Cell Lung Cancer
20%
Squamous Metaplasia
20%
Carcinoma in Situ
20%
Lung Alveolus Cell Carcinoma
20%
Cell Hyperplasia
20%
Hyperplasia
20%
Basal Cell
20%
Immunoreactivity
20%
Cell Membrane
20%
Keyphrases
Pulmonary Adenocarcinoma
100%
Precursor Lesions
100%
C4.4A
100%
Squamous Cell Carcinoma (SqCC)
100%
Adenocarcinoma Cells
100%
Adenocarcinoma
36%
Expression Level
18%
Immunoreactivity
9%
Atypical Hyperplasia
9%
Bronchial Epithelium
9%
Invasive Adenocarcinoma
9%
Lung Squamous Cell Carcinoma
9%
Hyperplasia
9%
Basal Cell Hyperplasia
9%
Squamous Differentiation
9%
Poor Survival
9%
Invasive Carcinoma
9%
Squamous Metaplasia
9%
Structural Homologs
9%
Prognostic Information
9%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
9%
Early Biomarker
9%
New Biomarkers
9%
Prognostic Impact
9%
Cell Membrane
9%
Carcinoma in Situ
9%
Dysplasia
9%
Non-small Cell Lung Cancer (NSCLC)
9%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Adenocarcinoma
100%
Invasive Carcinoma
20%
Squamous Cell Metaplasia
20%
Lung Alveolus Cell Carcinoma
20%